Description
Product: coated tablets, 125 mg of no. 30
Active substance: ethyl methylhydroxypyridine succinate
Indication: It is used for consequences of acute cerebrovascular accident; Neurotic and neurosis-like conditions with symptoms of anxiety; Neurocirculatory dystonia; Memory impairment and intellectual insufficiency in the elderly; Ischemic heart disease (stable angina of stress, unstable angina, acute myocardial infarction);
- Increases the survival of heart and brain cells under hypoxic conditions;
- Optimizes energy exchange in cells;
- Reduces intensity and struggles with the effects of oxidative stress;
- Stabilizes cell membranes and normalizes their functions;
- Normalizes microcirculation in ischemic tissues;
- Improves metabolism and blood supply of brain tissue;
- Enhances compensatory activation of aerobic glycolysis in ischemic conditions;
- Reduces the degree of damage to cellular structures resulting from hypoxia.
